Last updated on March 2020

A Study of Obinutuzumab Rituximab Polatuzumab Vedotin and Venetoclax in Relapsed or Refractory Follicular Lymphoma (FL) or Diffuse Large B-Cell Lymphoma (DLBCL)


Find a site near you

Start Over

The Queen Elizabeth Hospital

Adelaide, Australia
0.32miles
  Connect »